110.25
-0.6(-0.54%)
Currency In USD
Address
699 8th Street
San Francisco, CA 94103
United States of America
Phone
415 632 5700
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
2000
First IPO Date
October 20, 2016
| Name | Title | Pay | Year Born |
| Mr. Quentin S. Blackford | President, Chief Executive Officer & Director | 1.42M | 1979 |
| Mr. Daniel G. Wilson | Executive Vice President of Corporate Development & Investor Relations | 670,092 | 1982 |
| Dr. Minang P. Turakhia M.D., M.S. | Chief Medical & Scientific Officer and Executive Vice President of Product Innovation | 749,178 | 1974 |
| Mr. Patrick Michael Murphy J.D. | Chief Business & Legal Officer | 766,926 | 1979 |
| Mr. Chad M. Patterson | Chief Commercial Officer | 836,548 | 1982 |
| Mr. Mervin Smith | Executive Vice President of Business Operations | 0 | 1975 |
| Ms. Sumi Shrishrimal | Executive Vice President & Chief Risk Officer | 0 | 1979 |
| Ms. Stephanie Zhadkevich | Director of Investor Relations | 0 | N/A |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.